研究發現，志工電話訪談支持系統介入體重控制有提升遵醫囑 行為之效果，進而加強飲食與運動之行為改變，使得平均體重及身 體質量指數呈顯著的下降，達到減重之目的；代謝症候群指標也因 為體重減輕而有改善的情形，尤其以空腹血糖最為顯著。除此之 外，志工電話訪談支持系統介入體重控制亦使學員血清胰島素、總 膽固醇及低密度脂蛋白膽固醇濃度得以改善，達到健康促進之目 的。
因此，藉由志工電話訪談支持系統介入團體體重控制，可解決 一般傳統團體體重控制所面臨的瓶頸，提升體重控制之成效，進而 促進代謝症候群指標改善之效果。如此一套有效率之執行流程及有 效的志工電話訪談支持系統，可作為未來執行相關營養教育宣導的 依據；若能將此模式實際帶入全國社區健康營造中心運用，融合符 合在地需求之營養教育活動，必能實現健康城市之理想。
參考文獻
行政院衛生署（1998）1993-1996 國民營養健康狀況變遷調查結果。
行政院衛生署（2000）社區健康營造工作手冊，台北。
行政院衛生署（2002）肥胖定義及處理原則。
行政院衛生署（2006）94 年衛生統計系列-死因統計。
行政院衛生署國民健康局（2006）代謝症候群之判定標準。
呂淑娟（2004）小老師分組教學之初探。國立新竹師範學院進修暨推 廣部教師在職進修數理研究所碩士論文。
周立勳（1993）國小班級分組合作學習之研究。國立政治大學教育學 系博士論文。
胡幼慧（1995）社會流行病學。遠流出版社，台北。
陳建仁（1999）流行病學：原理與方法。聯經出版事業股份有限公司，
台北。
陳信任（2002）代謝症候群：各面向發生順序之探討。國立臺灣大學 流行病學學系碩士論文。
張峰紫、邱潤、章錫璋、蔡瑞熊（1991）糖尿病患者的家庭支持與其 認知、態度、遵從行為及糖化血色素控制之研究。護理雜誌 38:
59-69。
張珮嘉（2004）台中市四十歲以上民眾代謝症候群盛行率及相關因子 之探討。私立中國醫藥大學醫務管理學系碩士論文。
黃淑貞（1992）談病人遵醫囑行為之增進。衛生教育，台北。
Abbasi F, Brown BW, Lamendola C, McLaughlin T, and Reaven GM (2002) Relationship between obesity, insulinresistance, and coronary heart disease risk. Journal of the American College of Cardiology 40:
937-943.
Alberti KG, and Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:
diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 15: 539-553.
Aldana SG, Greenlaw RL, Diehl HA, Salberg A, Merrill RM, Ohmine S, and Thomas C (2006) The behavioral and clinical effects of
therapeutic lifestyle change on middle-aged adults. Preventing Chronic Disease 3: 1-16.
American Heart Association Scientific Statement (2000) AHA Dietary Guidelines Revision 2000. Circulation 102: 2284-2299.
American Heart Association. Metabolic syndrome increases risk of
coronary death. Internet:
http://www.americanheart.org/presenter.jhtml?identifier=3024259 (accessed 13 March 2006).
Anderson EA, Hoffman RP, Balon TW, Sinkey CA, and Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 87:
2246-2252.
Arai T, Yamashita S, Hirano KI, Sakai N, Kotani K, Fujioka S, Nozaki S, keno Y, Yamane M, and Shinohara E (1994) Increased plasma
cholesterol ester transfer protein in obese subjects : a possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arteriosclerosis and Thrombosis 14: 1129-1136.
Barbato A, Cappuccio FP, Folkerd EJ, Strazzullo P, Sampson B, Cook DG, and Alberti KGMM (2004) Metabolic syndrome and renal sodium handling in three ethnic groups living in England. Diabetologia 47:
40-46.
Becker MH (1985) Patient adherence to prescribed therapies. Medical Care 23: 539-555.
Becker MH and Maiman LA (1980) Strategies for enhancing patient compliance. Journal of Community Health 6: 113-135.
Beresford SAA, Curry SJ, Kristal AR, Lazovich D, Feng Z, and Wagner EH (1997) A dietary intervention in primary care practice: the eating patterns study. American Journal of Public Health 87: 610-616.
Black DR, Coe WC, Friesen JG, and Wutzmann AG (1984) Minimal interventions for weight control: a cost effective alternative.
Addictive Behaviors 9: 279-285.
Boden G and Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. European Journal of Clinical Investigation
Boucher A, Lu D, Burgess SC, Telemaque-Potts S, Jensen MV, Mulder H, Wang MY, Unger RH, Sherry AD, and Newgard CB (2004)
Biochemical mechanism of lipid-induced impairment of
glucose-stimulated insulin secretion and reversal with a malate analogue. Journal of Biological Chemistry 279: 27263-27271.
Brownell KD, and Cohen LR (1995) Adherence to dietary regimens 2:
components of effective interventions. Behavioral Medicine 20:
155-164.
Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, Accili D, Goodyear LJ, and Kahn CR(1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Molecular Cell 2:
559-569.
Cameron R, MacDonald MA, Schlegel RP, Young CI, Fisher SE, Killen JD, Rogers T, Horlick L, and Shepel LF (1990) Toward the
development of self-help health behavior change programs: weight loss by correspondence. Canadian Journal of Public Health 81:
275-279.
Chan YM, and Molassiotis A (1999) The relationship between diabetes knowledge and compliance among Chinese with non-insulin dependent diabetes mellitus in Hong Kong. Journal of advanced Nursing 30: 431-438.
Caro SDI, Hamad GG, Fernstrom MH, Schauer PR, and Bonanomi G (2006) Medical strategies for weight loss in the overweight and obese patient. Minerva Gastroenterologica E Dietologica 52:
415-430.
Chuang SY, Chen CH, Tsai ST and Chou P (2002) Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiologica Sinica 18:
16-23.
Cole HP, Berger PK, and Garrity TF (1988) Analogues between Medical and Industrial Safety Research on Compliance Behavior. Gochrran
DS: Health Behavior-Emerging Research Perspectives. New York Plenum Press, pp.267-280.
Coleman MP, Key TJA, Wang DY, Hermon C, Fentiman IS, Allen DS, Jarvis M, Pike MC, and Sanders TAB (1992) A prospective study of obesity, lipids, apolipoproteins and ischemic heart disease in women.
Atherosclerosis 92: 177-185.
Combs TP, Berg AH, Obici S, Scherer PE, and Rossetti L (2001)
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. Journal of Clinical Investigation 108: 1875-1881.
Dattilo AM, and Kris-Etherton PM (1992) Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. American Journal Clinical Nutrition 56: 320-328.
Graaf J, Hendriks JC, Demacker PN, and Stalenhoef AF (1993)
Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. Arteriosclerosis and Thrombosis 13: 712-719.
DeFronzo RA, Cooke CR, Andres R, Faloona GR, and Davis PJ (1975) The effect of insulin on renal handling of sodium, potassium,
calcium, and phosphate in man. Journal of Clinical Investigation 55:
845-855.
Dengel JL, Katzel LI, and Goldberg AP (1995) Effect of American Heart Association diet, with or without weight loss, on lipid in obese middle-aged and older men. American Journal Clinical Nutrition 62:
715-721.
Després JP (2006) Is visceral obesity the cause of the metabolic syndrome?
Annals of Medicine 38: 52-63.
Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, and Bouchard C (1990) Regional distribution of body fat, plasma
497-511.
Dracup KA, and Meleis AI (1982) Compliance an integrationist a approach. Nursing Research 31: 31-35.
Eckel RH (1989) Lipoprotein lipase. Amultifunctional enzyme relavant to common metabolic diseases. The New England Journal of Medicine 320: 1060-1068.
Eckel RH, Grundy SM, and Zimmet PZ (2005) The metabolic syndrome.
Lancet 365: 1415-1428.
Eckel RH, Yost TJ, and Jensen DR (1995) Alterations in lipoprotein lipase in insulin resistance. International Journal of Obesity and Related Metabolic Disorders 19: S16-S21.
Egan BM (2003) Insulin resistance and the sympathetic nervous system.
Current Hypertension Reports 5: 247-254.
Facchini F, Chen YD, Hollenbeck CB, and Reaven GM (1991)
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.
Journal of the American Medical Association266: 3008-3011.
Fernandez-Real JM, and Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews 24:
278-301.
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, and Bevilacqua S (1987) Insulin resistance in essential hypertension. The New England Journal of Medicine 17: 350-357.
Finer N (2006) Medical consequences of obesity. Medicine 34: 510-514.
Folsom AR, Szklo M, Stevens J, Liao F, Smith R, and Eckfeldt JH (1997) A prospective study of coronary heart disease in relation to fasting insulin, glucose and diabetes. Diabetes Care 20:935-942.
Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, and Nutrition Examination Survey. Journal of the American Medical Association 287: 356-359.
Graham LE, Taylor CB, Hovell MF, and Siegel W (1983) Five-year follow-up to behavioral weight-loss program. Journal of Consulting and Clinical Psychology 51: 322-323.
Grundy SM (1998) Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. American Journal of Cardiology 81:
18B-25B.
Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, and Kahn RA (2004) Clinical management of metabolic syndrome: report of the American
Heart Association/National Heart, Lung, and Blood
Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109: 551-556.
Haffner SM, Valdez RA, Hazuda HP, Mtchell BD, Morales PA, and Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 41: 715-722.
Hahn RA, Heath GW, and Chang MH (1998) Cardiovascular disease risk factors and preventive practices among adults-United States, 1994: a behavioral risk factor atlas. MMWR. CDC surveillance summaries 47: 35-69.
Haslam DW, and James WPT (2005) Obesity. Lancet 366: 1197-1209.
Heshka S, Yang MU, Wang J, Burt P, and Pi-Sunyer FX (1990) Weight loss and change in resting metabolic rate. American Journal of
Heyde S, Borhani NO, Tyroler HA, Schneider KA, Langford HG, Hames CG, Hutchinson R, and Oberman A (1985) The relationship of weight change to changes in blood pressure, serum uric acid,
cholesterol and glucose in the treatment of hypertension. Journal of Chronic Diseases 38: 281-288.
House JS (1981) The nature of social support. In work stress and social support reading. Addison-Wesley Publishing Company, pp.13-30.
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Speizer FE, Hennekens CH, and Willett WC (1999) Dietary protein and risk of ischemic heart disease in women. American Journal Clinical
Nutrition 70: 221-227.
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M-R, and Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
Jeffery RW, Bjornson-Benson WM, Rosenthal BS, Lindquist RA, Kurth CL, and Johnson SL (2004) Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men. Preventive Medicine 13: 155-168.
Jensen MD, Caruso M, Heiling V, and Miles JM (1989) Insulin regulation of lipolysis in nondiabetic and IDDN subjects. Diabetes 38:
1595-1601.
Joseph JW, Koshkin V, Saleh MC, Sivitz WI, Zhang CY, Lowell BB, Chan CB, and Wheeler MB (2004) Free fatty acid induced beta-cell defects are dependent on uncoupling protein 2 expression. Journal of Biological Chemistry 279: 15049-15056.
Kaplan NM (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of
Internal Medicine 149: 1514-1520.
Kayman S, Bruvold W, and Stern JS (1990) Maintenance and relapse
after weight loss in women: behavioral aspects. American Journal of Clinical Nutrition 52: 800-807.
Kant AK, Graubard BI, Schatzkin A, and Ballard-Barbash R (1995) Proportion of energy from fat subsequent weight change in the NHANS I Epidemiologic Follow-up Study. American Journal of Clinical Nutrition 61: 11-17.
Kylin E (1923) Studies of the hypertension-hyperglycemia-hyperuricemia syndrome (Studien ueber
dashypertonie-hyperglykamie-hyperurikamiesyndrome).
Zentralblattt Fuer Innere Medizin 44: 105-127.
Kim HS (2003) Adherence to diabetes control recommendations: impact of nurse telephone calls. Journal of Advanced Nursing 44: 256-261.
Kim YB, Shulman GI, and Kahn BB (2002) Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3. Journal of Biological Chemistry 277: 32915-32922.
Kris-Etherton PM, Taylor DS, Smiciklas-Wright H, Mitchell DC, Bekhuis TC, Olson BH, and Slonim AB (2002) High-soluble-fiber foods in conjunction with a telephone-based, personalized behavior change support service result in favorable changes in lipids and lifestyles after 7 weeks. Journal of the American Dietetic Association 102:
503-510.
Lakka HM, Laaksonen DE, Lakka TA, Tuomilehto LKJ, and Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 288: 2709-2716.
Lakka TA, Laaksonen DE, Lakka HM, Männikkö N, Niskanen LK, Rauramaa R, and Salonen JT (2003) Sedentary lifestyle, poor
cardiorespiratory fitness, and the metabolic syndrome. Medicine and Science in Sports and Exercise 35: 1279-1286.
Lam KSL, Xu A, Wat NMS, Tso AWK, and Ip MSM (2004) Obesity as the key player in the metabolic syndrome. International Congress Series 1262: 542-545.
Larson DE, Ferrao RT, and Ravussin E (1995) Energy metabolism in weight-stable postobese individual. American Journal of Clinical Nutrition 62: 735-739.
Layman DK, Shiue H, Sather C, Erickson DJ, and Baum J (2003)
Increased dietary protein modifies glucose and insulin homeostasis in adult women during weight loss. Journal of Nutrition 133:
405-410.
Lean MEJ (2006) Management of obesity and overweight. Medicine 34:
515-520.
Lee IM (1996) Is weight loss hazardous? Nutrition Review 54:
S117-S124.
Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, and Unger RH (1994) Beta-cell lipotoxicity in the pathogenesis of
non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proceedings of the National
Academy of Sciences of the United States 91: 10878-10882.
Leenen R, Kooy VD, Meyboorn S, and Seidell JC (1995) Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity. Journal of Lipid Research 34:
2183-2191.
Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA (2002) Blood pressure and clinical outcomes in the international stroke trial.
Stroke 33: 1315-1320.
Lewis BS and Lynch WD (1993) The effect of physician advice on exercise behavior. Preventive Medicine 22: 110-121.
Lewis GF, Uffelman KD, Szeto LW, Weller B, and Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. The Journal of Clinical Investigation 95: 158-166.
Lewis GF, and Steiner G (1996) Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin resistant
state. Diabetes Care 19: 390-393.
Lewis KS, Jennings AM, Ward C, and Brandley C (1990) Health belief scales developed specifically for people with tablet-treated type II Diabetes. Diabetic Medicine 7: 148-155.
Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, and Roberts SB (1999) High glycemic index foods, overeating, and obesity.
Pediatrics 103: E261-E266.
Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK,
Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, and Rewers M (2005) Low plasma adiponectin levels predict progression of coronary
artery calcification. Circulation 111: 747-753.
Manzato E, Zambon S, Zambon A, Cortella A, Sartore G, and Crepaldi G (1993) Levels and physicochemical properties of lipoprotein
subclasses in moderate hypertriglyceridemia. Clinica Chimica Acta 219: 57-65.
Matsuzawa Y, Funahashi T, Kihara S, and Shimomura I (2004)
Adiponectin and metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 29-33.
McGarry JD (1998) Glucose-fatty acid interactions in health and disease.
American Journal Clinical Nutrition 67: 500S-504S.
Medina J, Fernandez-Salazar LI, Garcia-Buey L, and Moreno-Otero R (2004) Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27: 2057-2066.
Michael S (1995) Epidemiology of obesity and its link to heart disease.
Metabolism 44: 1-3.
National Institute of Health (2001) Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel, or ATP III). National Institutes of Health Publication No.02-5215.
Neaton JD, and Wentworth D (1992) Serum cholesterol, blood pressure, cigarette smoking, and deaths from coronary heart disease. Overall findings and differences by age for 316,099 white men. Archives of Internal Medicine 152: 56-64.
Neuschwander-Tetri BA, and Caldwell SH (2003) Nonalcoholic
steatohepatitis: summary of an AASLD Single Topic Conference.
Hepatology 37: 1202-1219.
Orman AR (1971) The epidemiologic transition: a theory of the
epidemiology of population change. The Milbank Quarterly 49:
509-538.
Parker B, Noakes M, Luscombe N, and Clifton P (2002) Effect of a high-protein, monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 25:
425-430.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR and
Heymsfield SB (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.
Archives of Internal Medicine 163: 427-436.
Perri MG, McAllister DA, Gange JJ, Jordan RC, McAdoo WG, and Nezi AM (1988) Effects of four maintenance programs on the long-term management of obesity. Journal of Consulting & Clinical
Psychology 56: 529-534.
Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, and Rimm EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association 291:
1730-1737.
Pi-Sunyer FX (1993) Short-term medical benefit and adverse effects of weight loss. Annals of Internal Medicine 119: 722-726.
Racette SB, Schoeller DA, Kushner RF, and Neil KM (1995) Effects of aerobic exercise and dietary carbohydrate on energy expenditure and body composition during weight reduction in obese women.
American Journal Clinical Nutrition 61: 486-494.
Rasheed P (1998) Perception of body weight and self-reported eating and exercise behavior among obese and non-obese women in Saudi Arabia. Public Health 112: 409-414.
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
Ridker PM, Buring JE, Cook NR and Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events:
an 8-year follow-up of 14 719 initially healthy American women.
Circulation 107: 391-397.
Rydén A, Karlsson J, Persson LO, Sjöström L, Taft C, and Sullivan M
treatment preference. British Journal of Clinical Psychology 40:
177-188.
Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, and
McGovern PG (2000) Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the atherosclerosis risk in community study. Annals of Internal Medicine 133: 81-91.
Saltzman E, and Roberts SB (1996) The role energy expenditure in
energy regulation: finding from a decade research. Nutrition Review 53: 209-220.
Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, and Shulman GI (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Journal of Biological Chemistry 279: 32345-32353.
Schutz T, Tremblay A, Weinsier RL, and Nelson KM (1995) Role of fat oxidation in the long-term stabilization of body weight in obese women. American Journal Clinical Nutrition 55: 670-674.
Seidell JC (1998) Dietary fat and obesity: an epidemiologic perspective.
American Journal Clinical Nutrition 67: 546S-550S.
Seidell JC (2000) Obesity, insulin resistance and diabetes worldwide
Seidell JC (2000) Obesity, insulin resistance and diabetes worldwide